|
Index of reports
> Cases with Dyspnoea ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Epivir (Lamivudine) where reactions include dyspnoea. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Epivir side effects in male
Reported by a physician from France on 2012-04-24
Patient: male
Reactions: Dyspnoea, Pruritus, Skin Exfoliation, Tachycardia, Anaemia, General Physical Health Deterioration, Rash, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Epivir
Dosage: 150mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-03
Viread
Dosage: 245mg every 3 days
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-03
Isentress
Dosage: 400mg twice per day
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-03
Adcirca
Administration route: Oral
Indication: Pulmonary Arterial Hypertension
Start date: 2012-03-03
|
